This article needs additional citations for verification. (July 2018) |
AmpliChip is a family of clinical tests from the Swiss healthcare company Hoffmann-La Roche which aims to find out the patients' genotype using micro-array technology from Affymetrix (Genechip). The tests include the CYP450 Test and the P53 Test. The CYP450 Test was approved by the U.S. Food and Drug Administration.[1]
References edit
- ^ "China Approves First Microarray Platform For In Vitro Diagnostic Use". Asian Scientist Magazine | Science, technology and medical news updates from Asia. 2012-02-16. Retrieved 2018-07-25.